- CEO
- Tse Meng Ng
- Full Time Employees
- 2
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 111 Somerset, No. 05-06 Singapore Singapore 238164
- IPO Date
- Mar 24, 2022
- Business
- RF Acquisition Corp. (RFACU) operates as a blank-check company, or special purpose acquisition company (SPAC), whose primary purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses; it focuses its search for targets primarily on technology-based companies in Southeast Asia, including those in financial services, media, technology, retail, interpersonal communication, transportation, and education sectors, while also considering opportunities globally. The company has no significant current operations or revenue generation, relying instead on its raised capital from its initial public offering to pursue and complete a business combination within an 18-month timeframe from IPO. Founded in 2021 and headquartered in Singapore, RF Acquisition Corp. maintains a board and management team with extensive experience in private equity, venture capital, asset management, banking, and deal execution across Asia, led by Chairman and CEO Tse Meng Ng, a former banker with over 20 years at institutions including Credit Suisse and Citibank, and founder of Singapore-regulated Ruifeng Wealth Management. In its latest major development, RF Acquisition Corp. completed a business combination with GCL Global Holdings Ltd. on February 13, 2025, through a reverse merger, with RFAC surviving as a wholly owned subsidiary of the combined entity, GCL Group, whose ordinary shares (GCL) and warrants (GCLWW) began trading on Nasdaq shortly thereafter; shareholders had approved the transaction on January 23, 2025, following amendments to the original October 18, 2023 agreement, though heavy redemptions and delays impacted financing and projections. Prior to closing, the company extended its deadline multiple times, including approvals in September 2024 and November 2025 votes for further extensions amid ongoing regulatory filings and liquidity challenges indicated by a low current ratio of 0.03; concurrently, RF Acquisition Corp. II (RFAI), a related Cayman Islands entity formed in 2024 and also based in Singapore, announced a separate proposed $1.5 billion business combination with Nanyang Biologics Pte. Ltd. (NYB), an AI-driven drug discovery firm, on October 2, 2025, targeting Nasdaq listing under "NYB" in Q1 or Q2 2026 subject to approvals. Geographically, RF Acquisition Corp. leverages deep Asian networks for sourcing, screening, and executing deals, with its units (RFACU), shares (RFAC), warrants (RFACW), and rights (RFACR) having traded on Nasdaq Global Market since its $100 million IPO priced on March 22, 2022.